NASA is offering Fitbit devices to 1,000 mission-critical employees, including 150 astronauts, to mitigate the risk of spreading infectious disease among astronaut flight crews in the immediate preflight period.

The Mountain View, CA-based company won clearance from FDA for an expanded range of ECG determinations and had research with Mayo Clinic published in the peer-reviewed journal Circulation.

The OPRA Implant System has been on the market under a humanitarian device exemption since 2015 and is now fully approved by FDA for patients who have trouble with conventional socket prosthetics.

Reduced Medicare reimbursement rates is being cited as the main reason iRhythm's stock has tumbled, but is there more to the story than reimbursement?

The Marlborough, MA-based company has signed a multi-year agreement to integrate Google Cloud’s machine learning technologies with the Genius Digital System for the screening of cervical cancer.

Moray Medical is developing a interventional robotics platform powered by microfluidics and an augmented reality digital user interface. The company's initial focus is on the transcatheter mitral valve repair market.

The Chicago, IL-based company has acquired a contact-free continuous monitoring technology from EarlySense for $30 million with the potential for milestones.

Brennan Spiegel reveals a new kind of care in his book, "VRx: How Virtual Therapeutics Will Revolutionize Medicine."

The Valencia, CA-based company has raised $64 million in a preferred stock financing. SetPoint Medical said the financing will help move its pivotal trial for the development of its bioelectronic platform to treat rheumatoid arthritis.